🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

In Vivo Evaluation of the Accuracy of Immediate Screw-Retained Provisional Crowns Fabricated Using Digital Planning and Guided Surgery

RecruitingNAAges 18 Years - anyAllUniversidad Complutense de Madrid
NCT07315607 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This clinical trial aims to evaluate the in vivo accuracy of a fully digital workflow for the immediate placement of a previously fabricated screw-retained provisional crown using digital planning and guided implant surgery. The study will be conducted in partially edentulous adult patients requiring the replacement of a single tooth with an immediately loaded dental implant. The main objective of the study is to assess the accuracy (trueness and precision) of the planned digital implant position and provisional restoration by comparing the virtually planned position with the actual clinical outcome after guided surgery. Emphasis will be placed on linear, angular, and rotational deviations at both the implant and provisional restoration levels. Participants will undergo a fully guided implant placement procedure with rotational control, followed by the immediate placement of a prefabri

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Adults aged 18 years or older. 2. Partially edentulous patients requiring replacement of a single tooth with an immediately loaded dental implant. 3. Patients classified as ASA I or ASA II according to the American Society of Anesthesiologists physical status classification. 4. Patients with clinical conditions allowing immediate implant placement with a minimum primary stability of ≥25 Ncm. 5. Ability to understand the study procedures and provide written informed consent. 6. Willingness to comply with the study protocol and attend required clinical visits. Exclusion Criteria: 1. Patients classified as ASA III or ASA IV, or with uncontrolled systemic conditions that may interfere with study participation. 2. Presence of psychiatric or cognitive disorders that may compromise informed consent or protocol compliance. 3. Inability to comply with the visit schedule or required evaluations. 4. Any other condition that, in the investigator's judgment, could compromise patient safety, protocol adherence, or data validity.
💊

What it tests

  • Fully Guided Implant Placement and Immediate Provisionalization
📍

Where

1 site
Complutense University of Madrid
Madrid, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy